Roche: Maintaining high quality in the completion of a high potent OSD
Roche’s OSD manufacturing facility in Shanghai plays an important role in strengthening the company’s pharma business. Under the management of NNE the project was completed within an ambitious deadline and to high quality standards.
Referred to as SHiP II – short for Shanghai High Potent plant II – this highly complex project aims to enhance Roche’s existing high potent production capacity. This is achieved by adding a new facility adjacent but connected to the existing high potent oral solid dosage manufacturing at the company’s site in Shanghai and improving the handling systems for higher operator safety.
One of the purposes of the SHiP II facility is to support other facilities at the site – especially in improving the adjacent SHiP I – through unified purified water and high potent waste water system treatment. Additionally, to accommodate the customer’s future needs – and safeguard against risk – the design included a site storage facility with an explosion-proof room for components of the production.
A strategically important project
SHiP II is one of the initiatives in Roche’s 2018 master plan to develop its Shanghai site and the first fully integrated pharma hub in Asia Pacific. Hans Tanner, Head of project management China, explains the background for the project: “After a thorough analysis and feasibility study conducted during the Shanghai Site Master Planning Initiative in Q2 2012, it was clear that we needed to build additional highly active production capacity for China and for global supply. All this comes under SHiP II.”
From the outset, it was a focal point to maintain high quality standards, while at the same time keeping to a tight and fixed deadline in Q3 2015. This meant that the primary objective across every aspect of planning, design and construction was to maintain quality without losing momentum.